Cathie Wood’s Stock Portfolio: 2025 Stock Picks

Page 3 of 14

12. 10x Genomics, Inc. (NASDAQ:TXG)

ARK Investment Management’s Q3 Stake Value: $242.7 million

Number of Hedge Fund Holders: 29

10x Genomics, Inc. (NASDAQ:TXG), a biotechnology company based in California, develops gene sequencing technology for scientific research. The company sells a variety of items, including reagent kits, chromium controllers, informatics software, and 10x-compatible products. Cathie Wood recently made a significant investment in 10x Genomics Inc. (NASDAQ:TXG), with ARK purchasing 247,089 shares and investing $3,666,800 across its ARKK and ARKG ETFs. Wood’s belief in the genomics company is reflected in this move, which only adds to ARK’s recent accumulation trend in 10X Genomics.

According to the company’s unaudited financial results, Q4 revenue was around $165.0 million. In comparison to the same quarter last year, this figure represents a 10% decrease and a 9% sequential increase, with analysts expecting revenue of $153 million in the quarter. That said, despite a 37% decrease over the previous year, the company’s instrument sales, which include chromium and spatial instruments, increased 28% sequentially to $24.4 million. Consumables were another significant source of revenue for 10x Genomics, Inc. (NASDAQ:TXG), accounting for approximately $133.5 million.

Page 3 of 14